Decoy Wnt receptor sLRP6E1E2 decreases proliferation in human lung cancer cells. by Jung-Sun Lee (164985)

Resveratrol decreases cell proliferation in a time and dose dependent manner. by Mehtap Kilic Eren (591048)

Pendrin gene ablation increases force/cross-sectional area and decreases thickness of the aorta. by Roy L. Sutliff (485240)

Dexamethasone decreases CRTC1 and CRTC2 nuclear localization. by Jill A. Rahnert (2872766)

“…<p>Treatment of L6 myotubes with Dex (100nM, 48hrs) decreased (A) total CRTC1 (p = 0.004 and CRTC2 protein (p = 0.0007). n = 9/treatment from 3 experiments. …”

BA decreases mitochondrial membrane potential and superoxide production after one day of cell culture. by Bandik Föh (602419)

“…(G) Representative contour plots of CD138 and IL-10 GFP expression in isolated splenic B cells from IL-10 reporter mice after treatment with 0.5 mM BA and/or 100ng/ml PMA. (H) Frequencies of CD138^high PCs after treatment of isolated murine B cells with 0.5 mM BA and/or 100ng/ml PMA after 4 days of cell culture (n = 6). …”

RhoGTPase inhibition using TcdB and C3 transferase decreases transgene expression. by Anandika Dhaliwal (171763)

MeHg Exposure Makes O-2A/OPCs More Oxidized, Suppresses BrdU Incorporation, and Decreases Cell Division in Clonal Assays by Zaibo Li (273729)

“…<div><p>(A) Purified O-2A/OPCs were grown in the presence of 10-ng/ml PDGF overnight. …”

Mice carrying 100P mutations show layer-specific decreases in proportions of PV+ cells. by Malgorzata Borkowska (3166719)

“…<p>(<b>A-D</b>) Decreases occurred in layer IV in fSSp, SSp, vAud and Vis, in layer V in SSp, vAud and Vis and in layer II/III in SSp. …”

DNA damage induces a pan-nuclear decrease in GFP-lamin A mobility. by Robert Mahen (409641)

Dark-rearing during the visual sensitive period decreases MeCP2 expression within the dLGN. by Yuki Yagasaki (402238)

F-actin decreases after M64HCl treatment in Caco-2 cells. by Sema Oncel (10152053)

Dexamethasone decreases PGC-1α protein expression and transcription. by Jill A. Rahnert (2872766)

“…<p>(A) Treatment of L6 myotubes with Dex (100nM, 48hrs) decreased PGC-1α protein expression (p = 0.01). n = 3/treatment from 3 experiments. …”

D452A, E464A, E470A, and E475A mutations decreased the calcium sensitivity. by Qinghuan Xiao (573411)

Treatment with a highly reducing agent decreases ubiquitination of D_4.2R WT and D_{4.2 4KR}R mutant. by Kamila Skieterska (841014)

Confocal images presenting the phenotypes of S100A6-immunopositive cells in the SVZ. by Katarzyna Bartkowska (453261)

Subjects:

Confocal images presenting the phenotypes of S100A6-immunopositive cells in the ARH. by Katarzyna Bartkowska (453261)

Subjects:

GluN2A(D731N) reduces the agonist potency. by Kai Gao (120150)

Subjects:

Removal of the A-B linker did not decrease PIP₂ affinity. <i>A.-</i> by Paloma Aivar (124885)

Tetrandrine decreases Mtb antigen presentation. by Elham Karamooz (2584474)

Rho activation resulted in a growth cone collapse, but not decreased neurite lengths. by Frank Roloff (695802)